Design and Analysis of Group Sequential Trials for Repeated Measurements When Pipeline Data Occurs: A Tutorial

ABSTRACT Group sequential trials (GST) allow for early stopping of a clinical trial for efficacy or futility, without compromising its validity. Statistical methodology for GST is well established when the endpoint is observed immediately, but less so for endpoints that are measured with a delay, su...

Full description

Saved in:
Bibliographic Details
Published inStatistics in medicine Vol. 44; no. 13-14; pp. e70130 - n/a
Main Authors Baayen, Corine, Blanche, Paul, Jennison, Christopher, Ozenne, Brice
Format Journal Article
LanguageEnglish
Published Hoboken, USA John Wiley & Sons, Inc 01.06.2025
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text
ISSN0277-6715
1097-0258
1097-0258
DOI10.1002/sim.70130

Cover

Abstract ABSTRACT Group sequential trials (GST) allow for early stopping of a clinical trial for efficacy or futility, without compromising its validity. Statistical methodology for GST is well established when the endpoint is observed immediately, but less so for endpoints that are measured with a delay, such as repeatedly measured outcomes for which the primary measurement of interest is taken after several months. The latter can result in pipeline subjects at an interim analysis. These subjects may have early outcome measurements available, but their final endpoint is yet to be observed. Accounting for these early measurements has been shown to increase statistical power. Most importantly, pipeline patients will contribute with additional data after a decision to stop enrollment has been taken at an interim analysis. To make the best use of all available data, these data are ideally incorporated in the final analysis in a formal way. In this tutorial paper, we provide guidance on how to plan a GST with repeated measurements and a delayed endpoint and how to analyze the data resulting from these trials. We discuss existing methods, and also expand on them, for example adding a nonbinding stopping rule for futility and working out the computational details to derive valid p‐values and confidence intervals. We also provide an R package and R code to perform the methods discussed in this paper.
AbstractList Group sequential trials (GST) allow for early stopping of a clinical trial for efficacy or futility, without compromising its validity. Statistical methodology for GST is well established when the endpoint is observed immediately, but less so for endpoints that are measured with a delay, such as repeatedly measured outcomes for which the primary measurement of interest is taken after several months. The latter can result in pipeline subjects at an interim analysis. These subjects may have early outcome measurements available, but their final endpoint is yet to be observed. Accounting for these early measurements has been shown to increase statistical power. Most importantly, pipeline patients will contribute with additional data after a decision to stop enrollment has been taken at an interim analysis. To make the best use of all available data, these data are ideally incorporated in the final analysis in a formal way. In this tutorial paper, we provide guidance on how to plan a GST with repeated measurements and a delayed endpoint and how to analyze the data resulting from these trials. We discuss existing methods, and also expand on them, for example adding a nonbinding stopping rule for futility and working out the computational details to derive valid p ‐values and confidence intervals. We also provide an R package and R code to perform the methods discussed in this paper.
Group sequential trials (GST) allow for early stopping of a clinical trial for efficacy or futility, without compromising its validity. Statistical methodology for GST is well established when the endpoint is observed immediately, but less so for endpoints that are measured with a delay, such as repeatedly measured outcomes for which the primary measurement of interest is taken after several months. The latter can result in pipeline subjects at an interim analysis. These subjects may have early outcome measurements available, but their final endpoint is yet to be observed. Accounting for these early measurements has been shown to increase statistical power. Most importantly, pipeline patients will contribute with additional data after a decision to stop enrollment has been taken at an interim analysis. To make the best use of all available data, these data are ideally incorporated in the final analysis in a formal way. In this tutorial paper, we provide guidance on how to plan a GST with repeated measurements and a delayed endpoint and how to analyze the data resulting from these trials. We discuss existing methods, and also expand on them, for example adding a nonbinding stopping rule for futility and working out the computational details to derive valid p-values and confidence intervals. We also provide an R package and R code to perform the methods discussed in this paper.Group sequential trials (GST) allow for early stopping of a clinical trial for efficacy or futility, without compromising its validity. Statistical methodology for GST is well established when the endpoint is observed immediately, but less so for endpoints that are measured with a delay, such as repeatedly measured outcomes for which the primary measurement of interest is taken after several months. The latter can result in pipeline subjects at an interim analysis. These subjects may have early outcome measurements available, but their final endpoint is yet to be observed. Accounting for these early measurements has been shown to increase statistical power. Most importantly, pipeline patients will contribute with additional data after a decision to stop enrollment has been taken at an interim analysis. To make the best use of all available data, these data are ideally incorporated in the final analysis in a formal way. In this tutorial paper, we provide guidance on how to plan a GST with repeated measurements and a delayed endpoint and how to analyze the data resulting from these trials. We discuss existing methods, and also expand on them, for example adding a nonbinding stopping rule for futility and working out the computational details to derive valid p-values and confidence intervals. We also provide an R package and R code to perform the methods discussed in this paper.
ABSTRACT Group sequential trials (GST) allow for early stopping of a clinical trial for efficacy or futility, without compromising its validity. Statistical methodology for GST is well established when the endpoint is observed immediately, but less so for endpoints that are measured with a delay, such as repeatedly measured outcomes for which the primary measurement of interest is taken after several months. The latter can result in pipeline subjects at an interim analysis. These subjects may have early outcome measurements available, but their final endpoint is yet to be observed. Accounting for these early measurements has been shown to increase statistical power. Most importantly, pipeline patients will contribute with additional data after a decision to stop enrollment has been taken at an interim analysis. To make the best use of all available data, these data are ideally incorporated in the final analysis in a formal way. In this tutorial paper, we provide guidance on how to plan a GST with repeated measurements and a delayed endpoint and how to analyze the data resulting from these trials. We discuss existing methods, and also expand on them, for example adding a nonbinding stopping rule for futility and working out the computational details to derive valid p‐values and confidence intervals. We also provide an R package and R code to perform the methods discussed in this paper.
Author Baayen, Corine
Ozenne, Brice
Blanche, Paul
Jennison, Christopher
Author_xml – sequence: 1
  givenname: Corine
  surname: Baayen
  fullname: Baayen, Corine
  email: Corine.Baayen@ferring.com
  organization: Ferring Pharmaceuticals
– sequence: 2
  givenname: Paul
  surname: Blanche
  fullname: Blanche, Paul
  organization: University of Copenhagen
– sequence: 3
  givenname: Christopher
  surname: Jennison
  fullname: Jennison, Christopher
  organization: University of Bath
– sequence: 4
  givenname: Brice
  orcidid: 0000-0001-9694-2956
  surname: Ozenne
  fullname: Ozenne, Brice
  organization: Copenhagen University Hospital, Rigshospitalet
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40514767$$D View this record in MEDLINE/PubMed
BookMark eNp10UFP2zAUB3BrYhqF7cAXQJa4wCHtc1zHCbeqMIYEYlo77RgZ53kzSuxgJ0L99rhrtwMSl-fLz3_pvf8ROXDeISEnDKYMIJ9F200lMA4fyIRBJTPIRXlAJpBLmRWSiUNyFOMTAGMil5_I4RwEm8tCToi7wmh_O6pcQxdOtZtoI_WG3gQ_9nSFzyO6waqWrkOakRof6A_sUQ3Y0HtUcQzYJRLprz_o6HfbY2sd0is1KPqg9RjiJV3Q9Tj4bcBn8tGkGPyyf4_Jz6_X6-W37O7h5na5uMs0FwBZoYQSupk_msZI0KZhLGecg8KyNFWlC2i4BtDMGMVlIZSZs6LRhZElB6gEPybnu9w--LRCHOrORo1tqxz6MdY8Z6WUOS9Zomdv6JMfQzrFVuUVSClhG3i6V-Njh03dB9upsKn_XTKBix3QwccY0PwnDOptS3Vqqf7bUrKznX2xLW7eh_Xq9n734xUMM5HL
Cites_doi 10.1111/rssb.12225
10.1177/009286150804200402
10.1002/sim.10061
10.1186/s13063-022-06097-z
10.1080/10543400701645439
10.1177/009286150103500407
10.2307/2531502
10.1002/sim.8184
10.1002/sim.4102
10.1186/s13063-020-04526-5
10.1016/0197-2456(92)90017-T
10.1080/10543400701645215
10.1007/s12561-009-9004-3
10.1111/j.2517-6161.1989.tb01433.x
10.1111/j.1467‐9868.2012.01030.x
10.1002/sim.9580
10.1002/9781119238614
10.1111/1541-0420.00081
10.1093/biomet/89.3.699
10.2307/2333237
10.1007/978-3-319-32562-0
10.1093/biomet/74.1.149
10.1214/074921708000000039
ContentType Journal Article
Copyright 2025 John Wiley & Sons Ltd.
2025 John Wiley & Sons, Ltd.
Copyright_xml – notice: 2025 John Wiley & Sons Ltd.
– notice: 2025 John Wiley & Sons, Ltd.
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
K9.
7X8
DOI 10.1002/sim.70130
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
DatabaseTitleList CrossRef
MEDLINE
MEDLINE - Academic
ProQuest Health & Medical Complete (Alumni)

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Statistics
Public Health
EISSN 1097-0258
EndPage n/a
ExternalDocumentID 40514767
10_1002_sim_70130
SIM70130
Genre education
Journal Article
GroupedDBID ---
.3N
.GA
.Y3
05W
0R~
10A
123
1L6
1OB
1OC
1ZS
31~
33P
3SF
3WU
4.4
4ZD
50Y
50Z
51W
51X
52M
52N
52O
52P
52S
52T
52U
52W
52X
53G
5RE
5VS
66C
6PF
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A03
AAESR
AAEVG
AAHHS
AAHQN
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAWTL
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABIJN
ABJNI
ABOCM
ABPVW
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFS
ACPOU
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUYR
AEYWJ
AFBPY
AFFNX
AFFPM
AFGKR
AFWVQ
AFZJQ
AGHNM
AGQPQ
AGYGG
AHBTC
AHMBA
AITYG
AIURR
AIWBW
AJBDE
AJXKR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMVHM
AMYDB
ASPBG
ATUGU
AUFTA
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BDRZF
BFHJK
BHBCM
BMNLL
BMXJE
BNHUX
BROTX
BRXPI
BY8
CS3
D-E
D-F
DCZOG
DPXWK
DR2
DRFUL
DRSTM
DU5
DUUFO
EBD
EBS
EJD
EMOBN
EX3
F00
F01
F04
F5P
FEDTE
G-S
G.N
GNP
GODZA
H.T
H.X
HBH
HF~
HGLYW
HHY
HHZ
HVGLF
HZ~
IX1
J0M
JPC
KQQ
LATKE
LAW
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M67
MEWTI
MK4
MRFUL
MRSTM
MSFUL
MSSTM
MXFUL
MXSTM
N04
N05
N9A
NF~
NNB
O66
O9-
OIG
P2P
P2W
P2X
P4D
PALCI
PQQKQ
Q.N
Q11
QB0
QRW
R.K
RIWAO
RJQFR
ROL
RX1
RYL
SAMSI
SUPJJ
SV3
TN5
UB1
V2E
W8V
W99
WBKPD
WH7
WIB
WIH
WIK
WJL
WOHZO
WOW
WQJ
WXSBR
WYISQ
XBAML
XG1
XV2
YHZ
ZGI
ZXP
ZZTAW
~IA
~WT
AAMMB
AAYXX
AEFGJ
AGXDD
AIDQK
AIDYY
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
K9.
7X8
ID FETCH-LOGICAL-c3500-6a5a5cd4bfdf70cfd1121330ae88f99c60d3c00c1ffa3765af416dc6f78300953
IEDL.DBID DR2
ISSN 0277-6715
1097-0258
IngestDate Fri Jul 11 17:06:33 EDT 2025
Sun Aug 10 11:52:54 EDT 2025
Mon Jul 21 05:36:19 EDT 2025
Thu Aug 14 00:09:57 EDT 2025
Wed Jun 25 09:40:25 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 13-14
Keywords pipeline patients
delayed outcomes
error spending functions
group sequential trials
repeated measurements
Language English
License 2025 John Wiley & Sons Ltd.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3500-6a5a5cd4bfdf70cfd1121330ae88f99c60d3c00c1ffa3765af416dc6f78300953
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0001-9694-2956
OpenAccessLink https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/sim.70130
PMID 40514767
PQID 3229077705
PQPubID 48361
PageCount 24
ParticipantIDs proquest_miscellaneous_3218772381
proquest_journals_3229077705
pubmed_primary_40514767
crossref_primary_10_1002_sim_70130
wiley_primary_10_1002_sim_70130_SIM70130
PublicationCentury 2000
PublicationDate June 2025
2025-06-00
2025-Jun
20250601
PublicationDateYYYYMMDD 2025-06-01
PublicationDate_xml – month: 06
  year: 2025
  text: June 2025
PublicationDecade 2020
PublicationPlace Hoboken, USA
PublicationPlace_xml – name: Hoboken, USA
– name: England
– name: New York
PublicationTitle Statistics in medicine
PublicationTitleAlternate Stat Med
PublicationYear 2025
Publisher John Wiley & Sons, Inc
Wiley Subscription Services, Inc
Publisher_xml – name: John Wiley & Sons, Inc
– name: Wiley Subscription Services, Inc
References 2007; 17
1989; 45
1987; 74
2022; 23
2019; 38
2008
2011; 30
2007
2003; 59
2022; 41
1992; 13
1989; 51
1957; 44
1982; 69
2023
2000
2022
2021
2020
2002; 89
2013; 75
2017; 79
2019
2016
2024; 43
2013
2020; 21
2008; 42
2001; 35
2009; 1
e_1_2_13_25_1
e_1_2_13_24_1
R Core Team (e_1_2_13_20_1) 2021
e_1_2_13_27_1
e_1_2_13_26_1
e_1_2_13_21_1
Jennison C. (e_1_2_13_5_1) 2013
e_1_2_13_23_1
e_1_2_13_22_1
e_1_2_13_9_1
e_1_2_13_8_1
e_1_2_13_7_1
e_1_2_13_6_1
Fairbanks K. (e_1_2_13_33_1) 1982; 69
Jennison C. (e_1_2_13_2_1) 2000
e_1_2_13_17_1
e_1_2_13_18_1
e_1_2_13_19_1
e_1_2_13_13_1
e_1_2_13_14_1
e_1_2_13_15_1
e_1_2_13_16_1
e_1_2_13_32_1
e_1_2_13_10_1
e_1_2_13_31_1
e_1_2_13_11_1
e_1_2_13_12_1
e_1_2_13_30_1
e_1_2_13_4_1
e_1_2_13_3_1
e_1_2_13_29_1
e_1_2_13_28_1
References_xml – volume: 35
  start-page: 1095
  issue: 4
  year: 2001
  end-page: 1112
  article-title: Flexible Sample Size Considerations Using Information‐Based Interim Monitoring
  publication-title: Drug Information Journal
– volume: 1
  start-page: 95
  year: 2009
  end-page: 111
  article-title: Further Comments on the Alpha‐Spending Function
  publication-title: Statistics in Biosciences
– volume: 74
  start-page: 149
  issue: 1
  year: 1987
  end-page: 154
  article-title: Design and Analysis of Group Sequential Tests Based on the Type I Error Spending Rate Function
  publication-title: Biometrika
– volume: 51
  start-page: 305
  year: 1989
  end-page: 361
  article-title: Interim Analyses: The Repeated Confidence Interval Approach
  publication-title: Journal of the Royal Statistical Society, Series B
– volume: 13
  start-page: 106
  year: 1992
  end-page: 121
  article-title: Overrunning and Underrunning in Sequential Clinical Trials
  publication-title: Controlled Clinical Trials
– start-page: 595
  year: 2013
  end-page: 613
– year: 2007
– year: 2021
– volume: 30
  start-page: 3267
  year: 2011
  end-page: 3284
  article-title: Adaptive Increases in Sample Size When Interim Results Are Promising: A Practical Guide With Examples
  publication-title: Statistics in Medicine
– year: 2000
– volume: 21
  start-page: 668
  year: 2020
  article-title: Overrunning in Clinical Trials: Some Thoughts From a Methodological Review
  publication-title: Trials
– year: 2016
– volume: 41
  start-page: 5517
  issue: 28
  year: 2022
  end-page: 5536
  article-title: Group Sequential Methods for Interim Monitoring of Randomized Clinical Trials With Time‐Lagged Outcome
  publication-title: Statistics in Medicine
– volume: 79
  start-page: 1439
  year: 2017
  end-page: 1462
  article-title: A Bayesian Decision Theoretic Model of Sequential Experimentation With Delayed Response
  publication-title: Journal of the Royal Statistical Society. Series B, Statistical Methodology
– volume: 44
  start-page: 9
  issue: 1/2
  year: 1957
  end-page: 56
  article-title: Restricted Sequential Procedures
  publication-title: Biometrika
– volume: 17
  start-page: 1211
  year: 2007
  end-page: 1225
  article-title: Strategies for Including Patients Recruited During Interim Analysis of Clinical Trials
  publication-title: Journal of Biopharmaceutical Statistics
– year: 2008
– volume: 45
  start-page: 613
  issue: 2
  year: 1989
  end-page: 617
  article-title: Point Estimation Following Group Sequential Tests
  publication-title: Biometrics
– year: 2022
– volume: 42
  start-page: 303
  year: 2008
  end-page: 319
  article-title: Recommendations for the Primary Analysis of Continuous Endpoints in Longitudinal Clinical Trials
  publication-title: Drug Information Journal
– year: 2020
– volume: 38
  start-page: 3682
  year: 2019
  end-page: 3702
  article-title: Sequential Trials in the Context of Competing Risks: Concepts and Case Study, With R and SAS Code
  publication-title: Statistics in Medicine
– year: 2023
– volume: 75
  start-page: 3
  issue: 1
  year: 2013
  end-page: 54
  article-title: Group Sequential Tests for Delayed Responses (With Discussion)
  publication-title: Journal of the Royal Statistical Society, Series B: Statistical Methodology
– volume: 59
  start-page: 701
  year: 2003
  end-page: 709
  article-title: Incorporating Data Received After a Sequential Trial has Stopped Into the Final Analysis: Implementation and Comparison of Methods
  publication-title: Biometrics
– volume: 89
  start-page: 699
  year: 2002
  end-page: 707
  article-title: Sequential Tests and Estimators After Overrunning Based on Maximum‐Likelihood Ordering
  publication-title: Biometrika
– volume: 43
  start-page: 1
  issue: 12
  year: 2024
  end-page: 21
  article-title: A Two‐Stage Group‐Sequential Design for Delayed Treatment Responses With the Possibility of Trial Restart
  publication-title: Statistics in Medicine
– volume: 17
  start-page: 1135
  year: 2007
  end-page: 1161
  article-title: Adaptive Seamless Designs: Selection and Prospective Testing of Hypotheses
  publication-title: Journal of Biopharmaceutical Statistics
– volume: 69
  start-page: 69
  year: 1982
  end-page: 74
  article-title: P Values for Tests Using a Repeated Significance Test Design
  publication-title: Biometrika
– year: 2019
– volume: 23
  year: 2022
  article-title: Planning a Method for Covariate Adjustment in Individually Randomised Trials: A Practical Guide
  publication-title: Trials
– ident: e_1_2_13_24_1
– volume: 69
  start-page: 69
  year: 1982
  ident: e_1_2_13_33_1
  article-title: P Values for Tests Using a Repeated Significance Test Design
  publication-title: Biometrika
– ident: e_1_2_13_18_1
  doi: 10.1111/rssb.12225
– ident: e_1_2_13_21_1
– ident: e_1_2_13_19_1
– ident: e_1_2_13_22_1
  doi: 10.1177/009286150804200402
– ident: e_1_2_13_17_1
  doi: 10.1002/sim.10061
– ident: e_1_2_13_23_1
  doi: 10.1186/s13063-022-06097-z
– ident: e_1_2_13_14_1
  doi: 10.1080/10543400701645439
– ident: e_1_2_13_26_1
  doi: 10.1177/009286150103500407
– volume-title: R: A Language and Environment for Statistical Computing
  year: 2021
  ident: e_1_2_13_20_1
– ident: e_1_2_13_32_1
  doi: 10.2307/2531502
– ident: e_1_2_13_29_1
– ident: e_1_2_13_4_1
  doi: 10.1002/sim.8184
– ident: e_1_2_13_16_1
  doi: 10.1002/sim.4102
– ident: e_1_2_13_11_1
  doi: 10.1186/s13063-020-04526-5
– ident: e_1_2_13_9_1
  doi: 10.1016/0197-2456(92)90017-T
– volume-title: Group Sequential Methods With Applications to Clinical Trials
  year: 2000
  ident: e_1_2_13_2_1
– ident: e_1_2_13_8_1
– ident: e_1_2_13_30_1
  doi: 10.1080/10543400701645215
– ident: e_1_2_13_28_1
  doi: 10.1007/s12561-009-9004-3
– ident: e_1_2_13_12_1
  doi: 10.1111/j.2517-6161.1989.tb01433.x
– ident: e_1_2_13_7_1
  doi: 10.1111/j.1467‐9868.2012.01030.x
– ident: e_1_2_13_6_1
  doi: 10.1002/sim.9580
– ident: e_1_2_13_25_1
  doi: 10.1002/9781119238614
– ident: e_1_2_13_13_1
  doi: 10.1111/1541-0420.00081
– ident: e_1_2_13_15_1
  doi: 10.1093/biomet/89.3.699
– ident: e_1_2_13_31_1
  doi: 10.2307/2333237
– ident: e_1_2_13_3_1
  doi: 10.1007/978-3-319-32562-0
– ident: e_1_2_13_27_1
  doi: 10.1093/biomet/74.1.149
– ident: e_1_2_13_10_1
  doi: 10.1214/074921708000000039
– start-page: 595
  volume-title: Handbook of Survival Analysis
  year: 2013
  ident: e_1_2_13_5_1
SSID ssj0011527
Score 2.4653075
Snippet ABSTRACT Group sequential trials (GST) allow for early stopping of a clinical trial for efficacy or futility, without compromising its validity. Statistical...
Group sequential trials (GST) allow for early stopping of a clinical trial for efficacy or futility, without compromising its validity. Statistical methodology...
SourceID proquest
pubmed
crossref
wiley
SourceType Aggregation Database
Index Database
Publisher
StartPage e70130
SubjectTerms Clinical Trials as Topic - methods
Clinical Trials as Topic - statistics & numerical data
Data Interpretation, Statistical
delayed outcomes
Endpoint Determination - methods
error spending functions
group sequential trials
Humans
Models, Statistical
pipeline patients
repeated measurements
Research Design
Title Design and Analysis of Group Sequential Trials for Repeated Measurements When Pipeline Data Occurs: A Tutorial
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fsim.70130
https://www.ncbi.nlm.nih.gov/pubmed/40514767
https://www.proquest.com/docview/3229077705
https://www.proquest.com/docview/3218772381
Volume 44
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9RAEB9KH6QgfpwfjVYZxQdf7rqbzWYTfSqepQonYq_QByFs9gOKmivN3Yt_vTu7l5QqgvgSAtl87czO_mZm57cAr3IjmcnbeprzcCiCUzENbpANXkopc2IssrG2avGpPDkrPp7L8x14O9TCJH6IMeBGIyPaaxrguu0Pr0lD-4sfM0V5t2B_uSiJN3_-ZaSO4sN2rZSiLBWXA6sQyw_HO2_ORX8AzJt4NU44x3fh6_CpaZ3Jt9lm3c7Mz99YHP_zX-7BnS0QxaOkOfdhx3UTuLXYptoncDsF9DDVKU1gj2BpYnV-AN08LvxA3VkcaE1w5TFGsvA0Ls8OpuM7LqN-Y0DGGKB-sPvO4uI6LNljmAw6_HxxSWXxDud6rZGIj6_6N3iESyJYCA94CGfH75fvTqbbnRumRkgW_FEttTS2aL31ihlvOTHHCaZdVfm6NiWzwjBmuPc6WDipfcCF1pReVYJAn3gEu92qc_uAwgnHKx3kyHyhTVF5W1ttDalezdo6g5eDDJvLRNDRJCrmvAnd2sRuzeBgkG6zHaN9I4jqXinFZAYvxsthdFHKRHdutaE2vFK0LxvP4HHSivEtBVHHq1Jl8DrK9u-vb04_LOLJk39v-hT2ctpqOAZ8DmB3fbVxzwL-WbfPo6L_Au5Q_xE
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9RAFD7UCloQL6utqVWP4oMvu51cJpOIL8W1bLUpYrfQFwmTuUBpzZbu7ou_vnNmNilVBPElBDK5zbnMd87MfAfgXaI4U0lTDpPYHTIXVAxdGKRdlJLzhBiLtN9bVR3lk5Psyyk_XYOP3V6YwA_RJ9zIMry_JgOnhPTuDWvo_OznSNDE2x24mzmgQaHX-HtPHhV3BVtpkjIXMe94hViy2996ezT6A2LeRqx-yNl_BD-6jw0rTc5Hy0UzUr9-43H83795DA9XWBT3gvI8gTXTDuBetZptH8CDkNPDsFVpABuETAOx81Nox37tB8pWY8dsgjOLPpmFx36FtvMeFzj1Ko4OHKND-871G43VTWZyjm48aPHb2SXtjDc4lguJxH18Nf-AezgljgX3gGdwsv95-mkyXBVvGKqUMxeSSi650lljtRVMWR0TeVzKpCkKW5YqZzpVjKnYWumcHJfWQUOtciuKlHBfugnr7aw1zwFTk5q4kE6QzGZSZYXVpZZakfaVrCkjeNsJsb4MHB11YGNOatette_WCHY68dYrM53XKbHdCyEYj-BNf9kZGM2ayNbMltQmLgSVZosj2Apq0b8lI_Z4kYsI3nvh_v319fFB5U-2_73pa7g_mVaH9eHB0dcXsJFQ5WGf_9mB9cXV0rx0cGjRvPJafw3j1AM_
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LaxRBEC5ihBAQH-trNGopHrzspufZM3oKrkuibghmAzkIQ08_IKizS3b34q-3qntnQhRBvAwD0_Pqqur-qqrra4DXic6FTppqmMR0yMipGJIbZMhLKfKEGYuMr62aHheHZ9nH8_x8C951tTCBH6IPuLFl-PGaDXxh3P4Vaejy4sdIct7tBtzMCkISjIi-9NxRcbdfK-coCxnnHa2QSPb7W69PRn8gzOuA1c84kzvwtfvWsNDk22i9akb65280jv_5M3fh9gaJ4kFQnXuwZdsB7Ew3ufYB3AoRPQyFSgPYZVwaaJ3vQzv2Kz9QtQY7XhOcO_ShLDz167Np7PiOM6_gSNAYCevTwG8NTq_ikkuk2aDFk4sF18VbHKuVQmY-vly-xQOcMcMCPeABnE0-zN4fDjdbNwx1mgtySFWucm2yxhknhXYmZuq4VChblq6qdCFMqoXQsXOKhrhcOQKGRhdOlimjvvQhbLfz1j4GTG1q41KRHIXLlM5KZyqjjGbdq0RTRfCqk2G9CAwddeBiTmrq1tp3awR7nXTrjZEu65S57qWUIo_gZX-ZzItzJqq18zW3iUvJG7PFETwKWtG_JWPueFnICN542f799fXp0dSfPPn3pi9g52Q8qT8fHX96CrsJbzvsgz97sL26XNtnhIVWzXOv878A2owB7g
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Design+and+Analysis+of+Group+Sequential+Trials+for+Repeated+Measurements+When+Pipeline+Data+Occurs%3A+A+Tutorial&rft.jtitle=Statistics+in+medicine&rft.au=Baayen%2C+Corine&rft.au=Blanche%2C+Paul&rft.au=Jennison%2C+Christopher&rft.au=Ozenne%2C+Brice&rft.date=2025-06-01&rft.pub=Wiley+Subscription+Services%2C+Inc&rft.issn=0277-6715&rft.eissn=1097-0258&rft.volume=44&rft.issue=13-14&rft_id=info:doi/10.1002%2Fsim.70130&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0277-6715&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0277-6715&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0277-6715&client=summon